We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
(+14%)
Cap. Flow
+$330M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2
quarters
Top 10 Avg Time Held Equity + Options
1.2
quarters
Top 20 Avg Time Held Equity + Options
1.3
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.2
quarters
Top 20 Avg Time Held Equity only
1.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$269M |
| 2 |
Stericycle Inc
SRCL
|
+$141M |
| 3 |
Marathon Oil Corporation
MRO
|
+$108M |
| 4 |
ChampionX
CHX
|
+$103M |
| 5 |
Spirit AeroSystems
SPR
|
+$95.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitrans Midstream Corporation Common Stock
ETRN
|
+$149M |
| 2 |
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.8M |
| 3 |
Southwestern Energy Company
SWN
|
+$56.7M |
| 4 |
Union Pacific
UNP
|
+$24.2M |
| 5 |
US Steel
X
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 20.91% |
| 2 | Technology | 19.62% |
| 3 | Healthcare | 14.36% |
| 4 | Industrials | 11.13% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
PTC Therapeutics
PTCT
$5B
| $1.17M | 0.03% |
31,435
-1,565
| -5% | -$52.4K |
2022 Q4
7 quarters
|
|
252
Analog Devices
ADI
$201B
| $1.15M | 0.03% |
5,000
-2,500
| -33% | -$563K |
2024 Q2
1 quarter
|
|
253
Snowflake
SNOW
$126B
| $1.15M | 0.03% |
+10,000
| New | +$1.23M |
2024 Q3
0 quarters
|
|
254
Establishment Labs
ESTA
$1.74B
| $1.14M | 0.03% |
26,358
-2,087
| -7% | -$90.7K |
2022 Q1
10 quarters
|
|
255
DELISTED
AvalonBay Communities
AVB
| $1.14M | 0.03% |
5,049
+1,449
| +40% | +$313K |
2024 Q2
1 quarter
|
|
256
IQVIA
IQV
$42.9B
| $1.13M | 0.03% |
4,763
-1,553
| -25% | -$367K |
2024 Q2
1 quarter
|
|
257
Immunocore
IMCR
$1.43B
| $1.09M | 0.03% |
35,112
-4,902
| -12% | -$178K |
2022 Q1
10 quarters
|
|
258
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
| $1.09M | 0.03% |
100,248
-3,238
| -3% | -$35K |
2024 Q1
2 quarters
|
|
259
Apple Hospitality REIT
APLE
$3.91B
| $1.09M | 0.03% |
73,404
-56,573
| -44% | -$819K |
2023 Q3
4 quarters
|
|
260
argenx
ARGX
$50.5B
| $1.08M | 0.03% |
+2,000
| New | +$1.01M |
2024 Q3
0 quarters
|
|
261
DELISTED
Mersana Therapeutics
MRSN
| $1.08M | 0.03% |
22,801
+1,029
| +5% | +$45.4K |
2023 Q3
4 quarters
|
|
262
DELISTED
Haymaker Acquisition Corp 4
HYAC
| $1.07M | 0.03% |
100,248
-3,238
| -3% | -$34.3K |
2023 Q3
4 quarters
|
|
263
Iovance Biotherapeutics
IOVA
$6.57B
| $1.07M | 0.03% |
+113,777
| New | +$1.08M |
2024 Q3
0 quarters
|
|
264
Afya
AFYA
$1.28B
| $1.04M | 0.03% |
+60,897
| New | +$1.06M |
2024 Q3
0 quarters
|
|
265
X4 Pharmaceuticals
XFOR
$258M
| $1.04M | 0.03% |
51,645
+12,961
| +34% | +$270K |
2023 Q2
5 quarters
|
|
266
DELISTED
Paragon 28, Inc.
FNA
| $1.01M | 0.02% |
150,818
-15,925
| -10% | -$121K |
2023 Q1
6 quarters
|
|
267
enVVeno Medical
NVNO
$5.54M
| $995K | 0.02% |
8,458
+1,864
| +28% | +$342K |
2022 Q1
10 quarters
|
|
268
Karyopharm Therapeutics
KPTI
$9.69M
| $993K | 0.02% |
79,745
+6,252
| +9% | +$77.7K |
2022 Q1
10 quarters
|
|
269
Americold
COLD
$3.98B
| $990K | 0.02% |
+35,017
| New | +$1M |
2024 Q3
0 quarters
|
|
270
uniQure
QURE
$1.48B
| $977K | 0.02% |
198,223
+17,284
| +10% | +$113K |
2022 Q4
7 quarters
|
|
271
Phillips Edison & Co
PECO
$4.85B
| $977K | 0.02% |
+25,909
| New | +$924K |
2024 Q3
0 quarters
|
|
272
monday.com
MNDY
$3.58B
| $972K | 0.02% |
+3,500
| New | +$866K |
2024 Q3
0 quarters
|
|
273
Aura Biosciences
AURA
$650M
| $952K | 0.02% |
106,898
+16,279
| +18% | +$140K |
2023 Q2
5 quarters
|
|
274
Pliant Therapeutics
PLRX
$59.9M
| $952K | 0.02% |
84,885
+7,885
| +10% | +$98.7K |
2024 Q2
1 quarter
|
|
|
PKST
275
DELISTED
Peakstone Realty Trust
PKST
| $948K | 0.02% |
+69,531
| New | +$910K |
2024 Q3
0 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q3 2024 Portfolio in Review
As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.
By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.
- UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
- UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
- UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
- UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
- UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
- UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
- UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.
Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.